| Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores C Bianco, O Jamialahmadi, S Pelusi, G Baselli, P Dongiovanni, I Zanoni, ... Journal of hepatology 74 (4), 775-782, 2021 | 232 | 2021 |
| Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? R Younes, O Govaere, S Petta, L Miele, D Tiniakos, A Burt, E David, ... Gut 71 (2), 382-390, 2022 | 141 | 2022 |
| Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease R Younes, GP Caviglia, O Govaere, C Rosso, A Armandi, T Sanavia, ... Journal of hepatology 75 (4), 786-794, 2021 | 122 | 2021 |
| Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis A Santoliquido, A Porfidia, A Nesci, G De Matteis, G Marrone, E Porceddu, ... Journal of Thrombosis and Haemostasis 18 (9), 2358-2363, 2020 | 122 | 2020 |
| Reasons for tooth extractions and related risk factors in adult patients: a cohort study PC Passarelli, S Pagnoni, GB Piccirillo, V Desantis, M Benegiamo, ... International journal of environmental research and public health 17 (7), 2575, 2020 | 100 | 2020 |
| Liver involvement is not associated with mortality: results from a large cohort of SARS‐CoV‐2‐positive patients FR Ponziani, F Del Zompo, A Nesci, F Santopaolo, G Ianiro, M Pompili, ... Alimentary pharmacology & therapeutics 52 (6), 1060-1068, 2020 | 84 | 2020 |
| Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind. G Marrone, FG Vaccaro, M Biolato, L Miele, A Liguori, C Araneo, ... European Review for Medical & Pharmacological Sciences 21, 2017 | 62 | 2017 |
| Assessment of neurological manifestations in hospitalized patients with COVID‐19 M Luigetti, R Iorio, AR Bentivoglio, L Tricoli, V Riso, J Marotta, C Piano, ... European journal of neurology 27 (11), 2322-2328, 2020 | 54 | 2020 |
| COVID-19 and intestinal inflammation: Role of fecal calprotectin V Ojetti, A Saviano, M Covino, N Acampora, E Troiani, F Franceschi, ... Digestive and Liver Disease 52 (11), 1231-1233, 2020 | 50 | 2020 |
| Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta … FE Mózes, JA Lee, Y Vali, O Alzoubi, K Staufer, M Trauner, R Paternostro, ... The Lancet Gastroenterology & Hepatology 8 (8), 704-713, 2023 | 47 | 2023 |
| Fatty liver and drugs: the two sides of the same coin. L Miele, A Liguori, G Marrone, M Biolato, C Araneo, FG Vaccaro, ... European Review for Medical & Pharmacological Sciences 21, 2017 | 46 | 2017 |
| Rare ATG7 genetic variants predispose patients to severe fatty liver disease GA Baselli, O Jamialahmadi, S Pelusi, E Ciociola, F Malvestiti, M Saracino, ... Journal of Hepatology 77 (3), 596-606, 2022 | 45 | 2022 |
| Nonalcoholic fatty liver disease (NAFLD) as model of gut–liver axis interaction: From pathophysiology to potential target of treatment for personalized therapy F Fianchi, A Liguori, A Gasbarrini, A Grieco, L Miele International Journal of Molecular Sciences 22 (12), 6485, 2021 | 45 | 2021 |
| Use of imaging techniques for non-invasive assessment in the diagnosis and staging of non-alcoholic fatty liver disease L Miele, MA Zocco, F Pizzolante, N De Matthaeis, ME Ainora, A Liguori, ... Metabolism 112, 154355, 2020 | 31 | 2020 |
| Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets L Miele, MA Alberelli, M Martini, A Liguori, G Marrone, A Cocomazzi, ... Translational Research 231, 24-38, 2021 | 30 | 2021 |
| Liver transplantation for drug-induced acute liver failure. M Biolato, C Araneo, G Marrone, A Liguori, L Miele, FR Ponziani, ... European Review for Medical & Pharmacological Sciences 21, 2017 | 28 | 2017 |
| Circulating histone signature of human lean metabolic-associated fatty liver disease (MAFLD) D Buzova, A Maugeri, A Liguori, C Napodano, O Lo Re, J Oben, A Alisi, ... Clinical epigenetics 12, 1-15, 2020 | 24 | 2020 |
| Risk of burnout and stress in physicians working in a COVID team: A longitudinal survey T Dionisi, L Sestito, C Tarli, M Antonelli, A Tosoni, S D’Addio, A Mirijello, ... International Journal of Clinical Practice 75 (11), e14755, 2021 | 19 | 2021 |
| Mediterranean diet and the prevention of non-alcoholic fatty liver disease: results from a case-control study. L Giraldi, L Miele, K Aleksovska, F Manca, E Leoncini, M Biolato, D Arzani, ... European Review for Medical & Pharmacological Sciences 24 (13), 2020 | 18 | 2020 |
| The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: a pilot study. U Basile, L Miele, C Napodano, G Ciasca, F Gulli, K Pocino, ... European Review for Medical & Pharmacological Sciences 24 (24), 2020 | 17 | 2020 |
Antonio GasbarriniProfessor of Gastroenterology, Catholic University, Gemelli Hospital, Rome, ItalyVerified email at iol.it
